RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) FREE OF ALBUMIN, EFFICACY AND TOLERANCE IN PATIENTS WITH CHRONIC-RENAL-FAILURE (CRF) ON HEMODIALYSIS (HD)

被引：0
|
作者：
QUIROGA, MA [1 ]
LOCATELLI, A [1 ]
BARONE, R [1 ]
DEBENEDETTI, L [1 ]
GOMEZ, M [1 ]
机构：
[1] NEFROL SERV CLIN OLIVOS,BUENOS AIRES,ARGENTINA
来源：
KIDNEY INTERNATIONAL | 1993年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1413 / 1413
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL-FUNCTION IN CHRONIC-RENAL-FAILURE PREDIALYSIS PATIENTS
    ROTH, D
    SMITH, RD
    SCHULMAN, G
    STEINMAN, TI
    HATCH, FE
    RUDNICK, MR
    SLOAND, JA
    FREEDMAN, BI
    WILLIAMS, WW
    SHADUR, CA
    BENZ, RL
    TEEHAN, BP
    REVICKI, DA
    SAROKHAN, BJ
    ABELS, RI
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) : 777 - 784
  • [22] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ON THE HEMOSTATIC SYSTEM IN CHRONIC-HEMODIALYSIS PATIENTS
    HURAIB, S
    ALMOMEN, AK
    GADER, AMA
    MITWALLI, A
    SULIMANI, F
    ABUAISHA, H
    CLINICAL NEPHROLOGY, 1991, 36 (05) : 252 - 257
  • [23] CLINICAL EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ON ANEMIA ASSOCIATED WITH CHRONIC-RENAL-FAILURE - MULTICENTER COOPERATIVE STUDY IN JAPAN
    AKIZAWA, T
    KOSHIKAWA, S
    TAKAKU, F
    URABE, A
    AKIYAMA, N
    OTSUBO, O
    MIMURA, N
    NIHEI, H
    KAWAGUCHI, Y
    OTA, K
    KUBO, K
    ARTIFICIAL ORGANS, 1987, 11 (04) : 301 - 301
  • [24] THE ACTION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHE) ON PLATELET AND RED-CELL FUNCTION IN CHRONIC-RENAL-FAILURE PATIENTS ON HEMODIALYSIS
    RUDKO, IA
    BALASHOVA, TS
    KUATIEV, AA
    ERMOLENKO, VM
    TERAPEVTICHESKII ARKHIV, 1994, 66 (06) : 57 - 60
  • [25] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) FOR CORRECTION OF ANEMIA IN PATIENTS ON LONG-TERM HEMODIALYSIS (HD)
    WEISS, L
    WENTZEL, T
    FRISENETTEFICH, C
    HOFFSTEDT, E
    LINDBERGER, K
    MASCHER, G
    NIELSEN, F
    PRUTZ, K
    WESSEN, P
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 506 - 507
  • [26] IRON MANAGEMENT DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHRONIC-RENAL-FAILURE
    WATSON, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (12): : 1134 - 1138
  • [27] PHARMACOKINETICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN APPLIED SUBCUTANEOUSLY TO CHILDREN WITH CHRONIC-RENAL-FAILURE
    BRAUN, A
    DING, R
    SEIDEL, C
    FIES, T
    KURTZ, A
    SCHARER, K
    PEDIATRIC NEPHROLOGY, 1993, 7 (01) : 61 - 64
  • [28] RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) FOR CHRONIC-RENAL-FAILURE ANEMIA BEFORE DIALYSIS
    VALVERDE, CV
    APARICIO, CG
    TORREGROSA, M
    LLOPIS, LA
    KIDNEY INTERNATIONAL, 1991, 40 (02) : 365 - 366
  • [29] RECOMBINANT-HUMAN-ERYTHROPOIETIN AND CHRONIC-RENAL-FAILURE - PRESENT STATUS AND THERAPEUTIC IMPLICATIONS
    GONZALEZ, RR
    ESCUDER, PT
    MEDICINA CLINICA, 1990, 95 (17): : 656 - 659
  • [30] THE EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON MEAN CORPUSCULAR VOLUME IN PATIENTS WITH THE ANEMIA OF CHRONIC-RENAL-FAILURE
    SCHWARTZ, AB
    ORQUIZA, CS
    CLINICAL NEPHROLOGY, 1995, 43 (04) : 256 - 259
12345